Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands, Inc. (TLRY) delivered earnings and revenue surprises of -20% and 8.94%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?

Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates

Tilray Brands Inc. TLRY, +0.34% shares fell 3.7% in premarket trades Monday after the cannabis company said it swung to a second-quarter loss. Tilray posted a second-quarter loss of $61.64 million, or 11 cents a share, from a profit of $5.8 million, or breakeven per share, in the year-ago quarter.

Tilray swings to a loss, shares fall

Achieved $29.2 Million of Operating Cash Flow and $25.4 Million of Free Cash Flow

Tilray Brands Reports Second Quarter Fiscal Year 2023 Financial Results

Commercial Metals

At Thursday's opening bell, stocks traded lower. In the first few minutes of trading, the Nasdaq was down by about 1%, the S&P 500 by about 0.9% and the Dow Jones industrials 0.84% lower.

Earnings Previews: Commercial Metals, Tilray

Cronos Group

Marijuana Stocks To Watch The First Week Of The New Year The post 2 Canadian Marijuana Stocks To Watch Today In 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch Today In 2023

Aurora Cannabis

Canopy Growth

Cannabis trends and investment activity in 2023 are likely to be influenced by Congress's failure to pass the SAFE Banking Act.

Cannabis Trends to Watch for in 2023

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Constellation Brands

Most cannabis stocks lost roughly two-thirds of their value in 2022 as a lack of movement on federal prohibition, along with weakness in equity markets, weighed on the sector.

Cannabis stocks end a dismal year near all-time lows

HEXO Corp

Cannabis stocks are falling today on news that new regulation may be looming in 2023. Recent reports indicate the Food and Drug Administration (FDA) is planning a review of hemp-derived products including cannabidiol (CBD).

Why Are Cannabis Stocks TLRY, ACB, HEXO Down Today?

Plug Power

Select Wall Street analysts foresee up to 532% upside in these fast-paced companies for 2023.

4 Growth Stocks Expected to Skyrocket in 2023, According to Wall Street

A top figure in the marijuana reform effort effectively admits defeat, for now.

Why Pot Stocks Like Tilray and Aurora Crashed Hard Today

Will Canadian Pot Stocks Recover In 2023? The post Are Canadian Marijuana Stocks On Your 2023 Watchlist? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks On Your 2023 Watchlist?

There remains strong opposition to legalization of cannabis, particularly in more conservative areas of the United States and the rest of the world.

Cannabis Stocks Tumble On Third Failure Of SAFE Banking Act

Atai Life Sciences BV

SNDL Inc.

Stocks with big upside potential often have significant risks, too.

3 (Risky) Tricks for Finding Monster Growth Stocks

2022 just wasn't marijuana's year, but maybe 2023 will be?

Why Marijuana Stocks Keep Going Down

Trulieve Cannabis Corp.

The AdvisorShares Pure US Cannabis ETF MSOS, -2.49% dipped 2.8% as failure of the SAFE Banking measure to be included in Congress's omnibus spending bill weighed on the sector, but some stocks rose. Shares pared steeper losses from Monday, as reports surfaced the SAFE Banking was dead for the lame duck session.

Cannabis stocks fall as SAFE Banking measure officially fails; some stocks gain

NEW YORK and LEAMINGTON, Ontario, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that the Company will release financial results for its second quarter ended November 30, 2022 on January 9, 2023.

Tilray Brands, Inc. to Announce Second Quarter Fiscal 2023 Financial Results on January 9, 2023

Marijuana reform apparently isn't in the cards for the outgoing U.S. Congress.

Why Marijuana Stocks Like Tilray and SNDL Tanked Today

Borr Drilling Ltd

Riot Blockchain

Small-cap stocks to buy and hold don't have the same appeal as their blue-sip counterparts. Blue-chip stocks provide stability to the portfolio with low-beta stocks that also offer cash dividends.

3 Small-Cap Stocks to Buy and Hold for the Long Haul

First Drop of Limited Series Includes Exclusive Flower Strains Under ‘Orbital' Indica and ‘Crossfade' Sativa Collections First Drop of Limited Series Includes Exclusive Flower Strains Under ‘Orbital' Indica and ‘Crossfade' Sativa Collections

RIFF Cannabis Brand Launches New Series of Limited-Edition Strains in ‘Joint Effort' With Craft Growers

Anheuser-Busch InBev

Boston Beer Company

Recent studies suggest that cannabis could be a substitute product for alcohol.

Why More Beer Companies Could Soon Be Turning to Cannabis

Cannabis stocks aren't doing so hot on Wednesday as it appears banking legislation is unlikely to pass this year. Supporters of the bill have been attempting to add it to other legislation moving through Congress.

Why Are Cannabis Stocks Down Today?

Village Farms International

Is It Time To Buy Canadian Pot Stocks In December? The post Best Canadian Cannabis Stocks To Buy? 3 To Watch Before 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Cannabis Stocks To Buy? 3 To Watch Before 2023

Even if legalization takes place, it won't solve the problems of many cannabis producers, particularly those based in Canada.

Why Marijuana Legalization Shouldn't Be the Big Story for Cannabis Companies

As the saying goes, what a difference a day makes.

Why Tilray Stock Is Down More Than 20% This Week

Marijuana-related stocks reversed gains from earlier in the week as revelations emerged that a recent marijuana bill is unlikely to pass.

News for Tilray Brands Stock (TLRY)